Ruijiang Li Selected Research

Pathologic Complete Response

1/2021	Predicting treatment response from longitudinal images using multi-task deep learning.
1/2018	Intratumoral Spatial Heterogeneity at Perfusion MR Imaging Predicts Recurrence-free Survival in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruijiang Li Research Topics

Disease

40	Neoplasms (Cancer) 12/2023 - 08/2009
9	Lung Neoplasms (Lung Cancer) 09/2021 - 03/2009
9	Breast Neoplasms (Breast Cancer) 09/2019 - 11/2016
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 10/2016
5	Stomach Neoplasms (Stomach Cancer) 01/2023 - 01/2020
3	Neoplasm Metastasis (Metastasis) 09/2019 - 10/2016
3	AIDS-Related Complex (ARC) 03/2015 - 04/2013
2	Rectal Neoplasms (Rectal Cancer) 12/2023 - 01/2021
2	Pathologic Complete Response 01/2021 - 01/2018
2	Disease Progression 01/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 02/2017 - 12/2016
2	Prostatic Neoplasms (Prostate Cancer) 10/2016 - 07/2013
1	Tertiary Lymphoid Structures 01/2023
1	Melanoma (Melanoma, Malignant) 01/2022
1	Oropharyngeal Neoplasms 01/2019
1	Adenocarcinoma of Lung 11/2017
1	Margins of Excision 11/2017
1	Glioblastoma (Glioblastoma Multiforme) 02/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Arthrogryposis renal dysfunction cholestasis syndrome 05/2013
1	Pneumothorax 03/2009

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2016
3	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2020
2	Phenobarbital (Luminal)FDA Link 09/2019 - 10/2017
2	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2018
2	Estrogen ReceptorsIBA 01/2018 - 01/2017
2	RNA (Ribonucleic Acid)IBA 11/2017 - 02/2017
2	Contrast MediaIBA 11/2017 - 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 11/2023
1	Hematoxylin (Haematoxylon)IBA 11/2023
1	CytokinesIBA 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	histone H3 trimethyl Lys4IBA 10/2019
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	FluorineIBA 10/2016
1	antineoplaston A10 (A 10)IBA 05/2011

Therapy/Procedure

18	Radiotherapy 12/2023 - 03/2009
9	Therapeutics 01/2023 - 05/2010
7	Immunotherapy 01/2023 - 01/2020
5	Neoadjuvant Therapy 12/2023 - 11/2016
4	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 12/2013 - 05/2010
3	Drug Therapy (Chemotherapy) 12/2021 - 01/2020
2	Adjuvant Chemotherapy 01/2023 - 12/2021
1	Precision Medicine 09/2021
1	Chemoradiotherapy 01/2019
1	Adjuvant Radiotherapy 10/2018
1	Drug Tapering 03/2015
1	Particle Accelerators 07/2013
1	Image-Guided Radiotherapy 07/2011